Latest Breaking News On - Professor daniel offen - Page 1 : vimarsana.com

New TSXV listing looks to address the $3B spinal cord injury treatment market (NRX V)

The company is developing a novel, non-invasive, bio-guided treatment to restore function of patients with acute spinal cord injuries. Breakthrough th

Eli lillyShulamit levenbergHead of the lab for neurosciencesFelsenstein medical research centerIsrael institute of technologyTel aviv universityProfessor shulamit levenbergBiomedical engineering departmentProfessor daniel offenTel avivIsrael instituteCentral nerve systemFundamental analysis

NurExone Provides Corporate Update

NurExone Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShaowei guoLior shaltielNissim peretsExotherapy exoShulamit levenbergPolyrizon ltdIsrael patent officeNurexone biologic ltdService agreementNurexone biologic incVenture exchangeRegulation services providerNurexone researchTechnion researchIsrael newsfile corp

2022-07-13 | Press Release | NurExone Provides Corporate Update

(2022-07-13) NurExone Provides Corporate Update

United statesShaowei guoLior shaltielNissim peretsExotherapy exoShulamit levenbergPolyrizon ltdIsrael patent officeNurexone biologic ltdService agreementNurexone biologic incVenture exchangeRegulation services providerNurexone researchTechnion researchIsrael newsfile corp

Why Exosomes are a Billion Dollar Market: Innocan Pharma is leading the research

Exosome research has turned a corner through the groundbreaking work of Innocan Pharma.

Innocan pharmaTel aviv universityNeuroscience laboratory at tel aviv universityTheir cannabinoidsExosome delivery platformTel avivCannabinoids loaded exosomeNeuroscience laboratoryProfessor daniel offenInsider monkey

Innocan Pharma Announces the Filing by Ramot at Tel Aviv University of an International Patent Application for its Unique Cannabinoids Loaded Exosome Delivery Platform (CLX)

Innocan Pharma Announces the Filing by Ramot at Tel Aviv University of an International Patent Application for its Unique Cannabinoids Loaded Exosome Delivery Platform (CLX)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel generalTel avivIris bincovichKeren primor cohenInnocan pharmaIris bincovich innocanNeurology laboratoryat tel aviv universityCompany or innocanOffen of tel aviv universityInnocan pharma corporationDepartment of human geneticsLytham partnersInnocan pharma ltdHebrew university of jerusalemAlberta newsfile corpTel aviv university